Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes

INTRODUCTION: We compared the efficacy and safety of human regular insulin (HRI) versus rapid-acting insulin (RAI) in a type 2 diabetes population already using the V-Go insulin delivery device. RESEARCH DESIGN AND METHODS: This was a 14-week, multicenter, randomized, open-label, parallel-group, pha...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open Diabetes Res Care
Autors principals: Mora, Pablo F, Sutton, David R, Gore, Ashwini, Baliga, Bantwal, Goldfaden, Rebecca F, Nikkel, Carla, Sink II, John, Adams-Huet, Beverley
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Emerging Technologies, Pharmacology and Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7678232/
https://ncbi.nlm.nih.gov/pubmed/33214190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2020-001832
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars